LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device
Advanced Medical Solutions Limited · Decision date Jun 2, 2023
What did the FDA approve?
FDA records P220024 as an original PMA application. The recorded decision is approval, dated Jun 2, 2023.
FDA approval order statement
Approval for The LIQUIFIX FIX8 Hernia Mesh Fixation device is intended for use in laparoscopic surgical repair of groin (inguinal and femoral) hernias, achieved through the fixation of prosthetic polypropylene or polyester mesh to the abdominal wall and the approximation of the peritoneum.The LIQUIFIX Precision Open Hernia Mesh Fixation device is intended for use in open surgical repair of groin (inguinal and femoral) hernias, achieved through the fixation of prosthetic polypropylene or polyester mesh to the abdominal wall.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Jun 2, 2023
Regulatory record facts
- Identifier
- P220024
- Regulatory pathway
- Premarket approval application
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- Decision code
- APPR
- Decision date
- Jun 2, 2023
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tissue adhesive internal use.
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P220024 received
Application receipt date recorded by FDA.
P220024 · FDA decision
APPR
P220024/S007 · Related supplement
LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device
Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220024
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Advanced Medical Solutions Limited | PMA supplement | Oct 23, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Advanced Medical Solutions Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Western Wood Way, Langage Science Park, Plymouth, PL7 5BG
Sources and methodology
- Original FDA record: P220024
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records